
SILOTIME 4MG CAPS
Intas Pharmaceuticals Ltd - capsule - 4 mg - 15 S
Standard delivery
Distributor inventory | Tablet
Terbinafine 500 mg (as Terbinafine hydrochloride) tablet
Treatment of fungal infections of skin and nails such as onychomycosis (fungal nail infection), tinea corporis (ringworm), tinea cruris (jock itch), tinea pedis (athlete’s foot), and other dermatophyte infections as prescribed.
Terbinafine is an allylamine antifungal that inhibits squalene epoxidase, blocking ergosterol synthesis in fungal cell membranes. This leads to toxic accumulation of squalene and results in fungal cell death, especially against dermatophytes.
Tablet is taken by mouth exactly as prescribed. Can be taken with or without food; take at the same time each day. Duration depends on site and severity (skin infections usually weeks; nail infections often longer). Do not stop early without medical advice.
Common side effects of TEBINA 500MG TAB may include:

Intas Pharmaceuticals Ltd - capsule - 4 mg - 15 S
Standard delivery

Intas Pharmaceuticals Ltd - 15 S
Standard delivery

Intas Pharmaceuticals Ltd - capsule - 10 S
Standard delivery

Intas Pharmaceuticals Ltd - 10 S
Standard delivery

Intas Pharmaceuticals Ltd - 10 S
Standard delivery

Intas Pharmaceuticals Ltd - capsule - 25 mg - 10 S
Standard delivery

Intas Pharmaceuticals Ltd - capsule - 15 S
Standard delivery

Intas Pharmaceuticals Ltd - tablet - 25 mg - 15 S
Standard delivery
Prescription-only antifungal. Terbinafine can rarely cause serious liver injury—avoid/use with caution in liver disease; baseline and periodic liver function tests may be advised, and stop/seek care if jaundice, dark urine, persistent nausea/vomiting, right upper abdominal pain, unusual tiredness or itching occurs. Use caution in renal impairment. Rare severe skin reactions (SJS/TEN) and blood disorders have been reported—seek urgent care for widespread rash, fever, sore throat, easy bruising/bleeding. May worsen psoriasis or lupus in susceptible patients. Not for self-medication for prolonged use.